Thursday 13 September | |
GVC Holdings | Half Year Results |
WM Morrison Supermarkets | Half Year Results |
Faron Pharma | Half Year Results |
Oxford Biomedica | Half Year Results |
Biffa | Trading Statement |
Ophir Energy | Half Year Results |
Sound Energy | Half Year Results |
Amerisur Resources | Half Year Results |
Ricardo | Full Year Results |
Xeros Technology | Half Year Results |
Friday 14 September | |
JD Wetherspoon | Half Year Results |
Triple Point Social Housing | Half Year Results |
Avon Rubber | Trading Statement |
Sthree | Trading Statement |
PV Crystalox Solar | Half Year Results |
Investec | Trading Statement |
Monday 17 September | |
Restore | Half Year Results |
Dairy Crest | Trading Statement |
Quixant | Half Year Results |
MJ Gleeson | Full Year Results |
Team17 | Half Year Results |
Finsbury Food | Half Year Results |
Horizon Discovery Group | Half Year Results |
Warpaint London | Half Year Results |
City of London Investment Group | Full Year Results |
Tuesday 18 September | |
Ocado Group | Trading Statement |
DP Poland | Half Year Results |
Spire Healthcare | Half Year Results |
Be Heard | Half Year Results |
Bango | Half Year Results |
JTC | Half Year Results |
Faroe | Half Year Results |
Accys Technology | Half Year Results |
Keyword Studios | Half Year Results |
Green REIT | Full Year Results |
Personal Group Holdings | Half Year Results |
Smart Metering Systems | Half Year Results |
Cloudcall | Half Year Results |
AEW UK Long Lease REIT | Full Year Results |
Wednesday 19 September | |
Kingfisher | Half Year Results |
Babcock International | Trading Statement |
Stagecoach Group | Trading Statement |
RA International | Half Year Results |
Yu Group | Half Year Results |
Alliance Pharma | Half Year Results |
Cello Health Group | Half Year Results |
Accesso Technology | Half Year Results |
Greencoat Renewables | Half Year Results |
Quixant | Half Year Results |
IN BRIEF: Alliance Pharma drops as CEO departs, delays results again
Alliance Pharma PLC - Chippenham, Wiltshire-based distributor of consumer healthcare brands and prescription medicines - Shares close down 14% in London on Wednesday, after Alliance Pharma says Chief Executive Officer Peter Butterfield has decided to leave the company "to pursue other business interests". Following a "comprehensive" search process, it appoints Nick Sedgwick as new CEO, starting on Monday next week. Sedgwick has 30 years experience in consumer health, Alliance Pharma says, most recently as regional director for UK & Ireland Consumer Health at Reckitt Benckiser Group PLC. Butterfield will remain with Alliance Pharma until June 30 to facilitate a "thorough" handover, it says. Butterfield joined the board in 2010 and became CEO in 2018.
Read more